All advisers

Exempt Reporting Adviser

Mccaslin Barrow Henderson, LLC

CRD 164383

Registration facts are from the firm's Form ADV Part 1A as published by the SEC, latest filing dated April 1, 2026. Figures are firm-level: they describe the advisory firm, not any single offering.

Registration

Status
ERA - Active
Registered since
July 11, 2012
Principal office
5310 Harvest Hill Road, Suite 250, Dallas, TX 75230
Organized as
Limited Liability Company, TX
Fiscal year end
December
Other offices
1
Website
mh-cap.com
Full record on SEC IAPD

Scale

Private funds advised
11
Private fund gross assets
$51.4M
Fund types
11 real estate funds
Funds with Form D records
11 issuers in AltStreet's ledger, $45.4M reported sold across them

Form ADV Item 11 disclosures

No yes answers on Item 11 as of the latest Form ADV (April 1, 2026). Item 11 covers the firm and its advisory affiliates.

Form D activity of the funds this firm advises, by year

11 issuers in AltStreet's EDGAR ledger are joined to this adviser through Form ADV Schedule D, with Form D filings from June 9, 2016 to August 18, 2025. Reported sold across them: $45.4M.Years are the year of each offering's first notice; sold and investors are the latest figures on each chain. Counts and totals only; the fund roster is in the terminal.

First noticeOfferingsReported soldInvestors
20252$8.3M46
20242$14.5M47
20232$2.6M31
20221$4.2M31
20211$3.1M24
20201$4.2M20
20171$4.5M35
20161$4.2M18

In the directory

Related advisers

Is this your firm? Verified Profiles give managers a structured channel for corrections, additional disclosures, and right of reply, without changing AltStreet's independent research. Learn about verification →

Source: SEC Form ADV via IARD (roster of October 6, 2026), matched to the platform by AltStreet analysts. Item 11 answers are as reported on the firm's Form ADV and cover the firm and its advisory affiliates; consult the firm's IAPD record for the Disclosure Reporting Pages. Brochure statements are the firm's own. Nothing on this page is investment advice.